Stock listing

Celltrion Pharm Inc.

Selected listing: 068760 · KRX · KRW · KR

Celltrion Pharm Inc. (KRX:068760), Health Technology. Latest release Sep 17, 2025: Celltrion Pharm Signs Strategic Trilateral Agreement with Becton Dickinson…

068760:KRXKRWKRUpdated September 25, 2026
Celltrion Pharm Inc. logo
Ticker
KRX:068760
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
KRX
Currency
KRW

About Celltrion Pharm Inc.

Celltrion Pharm Inc. is a publicly traded company on the Korean stock market, identified by the ticker 068760. Celltrion focuses on developing and manufacturing biopharmaceutical products.

Latest news from Celltrion Pharm Inc.

Celltrion Pharm Signs Strategic Trilateral Agreement with Becton Dickinson and BD Korea to Accelerate Global PFS CMO Business

September 16, 2025

Samsung Bioepis Enters into Commercialization Agreement for Next-Generation Biosimilar Candidates

November 7, 2019

All Celltrion Pharm Inc. news →

Research Celltrion Pharm Inc.

Celltrion Pharm Inc. company profile

View the public company page for Celltrion Pharm Inc. on 6ix.

Celltrion Pharm Inc. news

Read company news and market updates connected to Celltrion Pharm Inc..

Celltrion Pharm Inc. investor events

Find investor webinars, events, and replay context for Celltrion Pharm Inc..